Skip to main content

Proteomics Hits the Syllabus, Thanks to PNNL's Bigelow

Premium

Most college professors never get to teach a course exactly the way they want. Biochemist and educator Diana Bigelow, 50, however, has the upper hand in the way an entire program will be run. She’s designing her own post-genomics curriculum from scratch.

“Most of us go into a faculty position and take up a program that was arrived at through various historical or evolutionary means,” says Bigelow, a former director at the University of Kansas mol-bio department whose focus is proteomics. “It may not be exactly what you want.”

Following a hand-me-down syllabus is something Bigelow doesn’t have to worry about. Since January, she has been working with the Department of Energy’s Pacific Northwest National Laboratory to create a postgraduate molecular biosciences program at Washington State University’s Tri-Cities campus. Bigelow hopes that the program will be operational in 2003.

“We’re now in the post-genomics era,” she says. “Even though we have DNA sequences for more than half of the genes, we don’t know what they code for in terms of protein function.”

Since Bigelow is known for calcium regulation research, calcium signaling will be one of the areas that students will be able to choose from. But the proteome, she argues, remains “the key deal” to elucidating protein pathways. The chance to investigate this at PNNL couldn’t be more thrilling.

“Coming to a national lab is really exciting for me scientifically because they have very impressive facilities,” Bigelow says. “We’re in an era where high-throughput computer facilities and capabilities are really going to be important.”

— Jasmin Chua

The Scan

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.